On July 17, the managed products of two star fund managers under Ruiyuan Fund revealed the 2026 second quarter report, and their latest top ten heavy-held stocks also surfaced. During the second quarter of 2026, the Hong Kong stock positions of the Ruiyuan Growth Value Hybrid Fund, managed by Fu Pengbo and Zhu Yi, fell to their lowest level in history. In terms of position transfer and stock exchange, the fund opened a position with Juguang Technology for the first time, and drastically reduced its holdings of Zhongji Xuchuang and Dongshan Precision. Ruiyuan Equilibrium Value, managed by Zhao Feng, another star fund manager of Ruiyuan Fund, was held for three years, then bought back Yao Ming Biotech after a lapse of one year, and also increased its holdings in Zhongtong Express and China Resources Land.

On July 17, the managed products of two star fund managers under Ruiyuan Fund revealed the 2026 second quarter report, and their latest top ten heavy-held stocks also surfaced. During the second quarter of 2026, the Hong Kong stock positions of the Ruiyuan Growth Value Hybrid Fund, managed by Fu Pengbo and Zhu Yi, fell to their lowest level in history. In terms of position transfer and stock exchange, the fund opened a position with Juguang Technology for the first time, and drastically reduced its holdings of Zhongji Xuchuang and Dongshan Precision. Ruiyuan Equilibrium Value, managed by Zhao Feng, another star fund manager of Ruiyuan Fund, was held for three years, then bought back Yao Ming Biotech after a lapse of one year, and also increased its holdings in Zhongtong Express and China Resources Land.